Overcoming resistance of targeted EGFR monotherapy by inhibition of STAT3 escape pathway in soft tissue sarcoma
about
Combination treatment including targeted therapy for advanced hepatocellular carcinomaNext-generation EGFR/HER tyrosine kinase inhibitors for the treatment of patients with non-small-cell lung cancer harboring EGFR mutations: a review of the evidenceNiclosamide inhibition of STAT3 synergizes with erlotinib in human colon cancer.Significance of Phosphorylated Epidermal Growth Factor Receptor and Its Signal Transducers in Human Soft Tissue Sarcoma.Kinome and Transcriptome Profiling Reveal Broad and Distinct Activities of Erlotinib, Sunitinib, and Sorafenib in the Mouse Heart and Suggest Cardiotoxicity From Combined Signal Transducer and Activator of Transcription and Epidermal Growth Factor REGFR is involved in dermatofibrosarcoma protuberans progression to high grade sarcoma.
P2860
Overcoming resistance of targeted EGFR monotherapy by inhibition of STAT3 escape pathway in soft tissue sarcoma
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Overcoming resistance of targe ...... pathway in soft tissue sarcoma
@en
type
label
Overcoming resistance of targe ...... pathway in soft tissue sarcoma
@en
prefLabel
Overcoming resistance of targe ...... pathway in soft tissue sarcoma
@en
P2093
P2860
P356
P1433
P1476
Overcoming resistance of targe ...... pathway in soft tissue sarcoma
@en
P2093
David Goldstein
Jia-Lin Yang
Kerryn Garrett
Nikolajs Zeps
Xiaochun Wang
P2860
P304
21496-21509
P356
10.18632/ONCOTARGET.7452
P407
P577
2016-02-17T00:00:00Z